Morningside Ventures
Asia, Hong Kong Island, Hong Kong, Central'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
Morningside Ventures is an investment firm.
Investor Profile
Morningside Ventures has backed more than 16 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 31% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States, China, United Kingdom.
- Strong thematic focus on Health Care, Biotechnology, Medical Device.
Stage Focus
- Series B (31%)
- Series C (25%)
- Series A (19%)
- Post Ipo Equity (6%)
- Private Equity (6%)
- Seed (6%)
- Series D (6%)
Country Focus
- United States (50%)
- China (19%)
- United Kingdom (19%)
- Singapore (6%)
- The Netherlands (6%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Artificial Intelligence (Ai)
- Therapeutics
- Medical
- Health Diagnostics
- Life Science
- Pharmaceutical
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Morningside Ventures frequently co-invest with?
Which angels does Morningside Ventures often collaborate with?
What are some of recent deals done by Morningside Ventures?
Find More Investors Like Morningside Ventures
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









